|
|
|
By Louis Garguilo, Chief Editor, Outsourced Pharma | Mark Butchko has been at Eli Lilly for 24 years, currently serving as Associate Vice President - Global Quality Laboratories. He draws from that longevity to describe what he’s currently experiencing, and what the future of outsourcing might look like from his vantage point. |
|
|
Super Generics: Market Trends In Europe | By Sabyasachi Ghosh and Arun Kumar Gautam, Future Market Insights | Super generics combine advanced formulations and delivery methods, and improved bioavailability, compared to traditional generics. This article shares the market research trends of the European market. |
|
|
|
|
|
|
|
Lab Equipment And Testing Site Matrix | Cambrex | Our analytical and testing services are offered as both standalone services as well as complementing our expertise in drug substance and drug product development and manufacturing depending on your specific program needs. |
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
